0001127602-18-021850.txt : 20180625 0001127602-18-021850.hdr.sgml : 20180625 20180625170307 ACCESSION NUMBER: 0001127602-18-021850 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180621 FILED AS OF DATE: 20180625 DATE AS OF CHANGE: 20180625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHON PAUL A CENTRAL INDEX KEY: 0001231589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 18917618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-06-21 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231589 MAHON PAUL A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 EVP & General Counsel Common Stock 2018-06-21 4 M 0 6000 61.06 A 41613 D Common Stock 2018-06-21 4 D 0 6000 116.73 D 35613 D Share Tracking Award 61.06 2018-06-21 4 M 0 6000 0 D 2014-03-15 2023-03-15 Common Stock 6000 55000 D This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. /s/ John S. Hess, Jr. under Power of Attorney 2018-06-22